ARSUF (Fagron) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


ARSUF Fagron SA ARSUF
91 GF Score
Price $26.53
GF Value $25.96
! 6 Warning Signs
View Full Analysis

What is Fagron Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Fagron's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

ARSUF vs ZTS, UTHR, VTRS: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fagron's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fagron Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fagron's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Fagron's Margin of Safety % (DCF Earnings Based) falls into.


ARSUF
91GF Score
Fagron SA ARSUF
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fagron (ARSUF) Overvalued in 2026?

Based on GuruFocus' analysis, Fagron stock appears to be overvalued. The current stock price of $26.53 is trading 2.2% above its estimated GF Value™ of $25.96.

Key valuation signals for ARSUF:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $25.96 vs. price of $26.53 (2.2% above fair value)
  • GF Score™: 91/100 with 6 warning signs

No single metric tells the full story. See the ARSUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fagron Business Description

Address Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Fagron SA is a Belgium-based multinational pharmaceutical compounding company specializing in pharmaceutical compounding. It operates across the pharmaceutical compounding value chain, developing and manufacturing personalized medicines in collaboration with pharmacists, prescribers, hospitals, and other healthcare providers. The company has three segments: Essentials, Brands, and Compounding Services. The majority of the revenue is derived from the Essentials segment, which provides raw materials, equipment, packaging, and supplies for compounding to pharmacies and healthcare industries across EMEA, Latin America, and North America - Pacific. Geographically, it generates the maximum revenue from Fagron North America - Pacific.
91GF Score

Get the complete analysis for ARSUF

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.53
Price
$25.96
GF Value